StonvexLoading…
StonvexStonvexStonvexCore line items from NRXS's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
Quarterly filings sourced directly from SEC EDGAR. Real-time earnings actuals are in the Earnings panel above.
| Metric | Q1 2026 2026-03-31 | Annual 2025 2025-12-31 | Q3 2025 2025-09-30 | Q2 2025 2025-06-30 |
|---|---|---|---|---|
Revenue | $1.61M | $3.57M | $2.60M | $1.79M |
Operating Income | $-1.74M | $-7.83M | $-6.11M | $-4.01M |
Net Income | $-1.76M | $-7.80M | $-6.09M | $-1.69M |
EPS (Diluted) | $-0.18 | $-0.95 | $-0.78 | $-0.56 |
Total Assets | $8.75M | $6.40M | $5.78M | $7.09M |
Total Liabilities | $3.00M | $3.00M | $3.49M | $2.83M |
Cash & Equivalents | $7.08M | $4.97M | $4.38M | $5.99M |
Free Cash Flow OCF − CapEx | Not available | $-6.46M | $-4.52M | $-3.10M |
Shares Outstanding | 11.45M | 10.65M | 9.89M | 9.86M |